Drugs targeted by IRA over price named by HHS

The US Department of Health and Human Services (HHS)—through the Centers for Medicare and Medicaid Services (CMS)—has announced that some Medicare enrollees will pay less for 64 drugs available through Medicare Part B.

Under President Biden’s Inflation Reduction Act (IRA), some people with Medicare will pay less for certain Part B drugs if the product’s price increased faster than the rate of inflation.

The drugs will have a lowered Part B coinsurance rate from July 1 to September 30, since each drug company raised prices faster than the rate of inflation.